Patent Brokerage

A patent broker is an intermediary who facilitates patent transactions — matching sellers to buyers and guiding both parties through the transaction process: WHAT A PATENT BROKER DOES: (a) SELLER ENGAGEMENT: the broker evaluates the patent portfolio, assesses market value, and determines whether the patents are marketable; not all patents are worth brokering; (b) PORTFOLIO PREPARATION: brokers prepare marketing materials including patent claim charts, landscape analyses showing competitive positioning, and licensing revenue history; (c) BUYER IDENTIFICATION: brokers maintain relationships with likely buyers — operating companies in the relevant technology space, portfolio companies, defensive aggregators (RPX, Unified Patents), and PAEs; (d) BLIND PACKAGES: brokers typically send teaser packages (which identify the patent numbers and technology area but not always the seller) under NDA; (e) DEAL NEGOTIATION: brokers structure the transaction, negotiate price and terms, and guide the parties through due diligence; (f) CLOSING: brokers coordinate the execution of patent assignment agreements and the transfer of consideration; WHEN TO USE A BROKER: (a) when your company is divesting non-core IP and lacks an internal IP monetization team; (b) when a startup or inventor wants to sell patents but doesn't have buyer relationships; (c) when a company exits bankruptcy and its IP assets must be liquidated; (d) when an operating company wants to build a portfolio defensively and needs to source assets; BROKER COMPENSATION: sellers typically pay a success fee (commission) of 10-25% of the transaction value; for smaller transactions (<$1M), commissions may be higher; some brokers also charge retainers or minimum fees; ALTERNATIVES TO BROKERS: companies with established IP teams sometimes sell directly to known buyers or through patent auctions (Ocean Tomo, Richardson Oliver) instead of engaging a broker.

Preparation before engaging a broker significantly affects sale price and buyer interest: STEP 1 — PORTFOLIO ASSESSMENT: identify which patents are candidates for sale; key factors: (a) remaining patent term (patents with less than 2-3 years of life have limited value); (b) claim breadth (broad claims covering widely used technology are most valuable); (c) forward citation count (heavily cited patents are often more foundational and more valuable); (d) prosecution history (clean prosecution = easier licensing; heavily amended claims with narrow scope = less valuable); (e) whether the patent covers a product or process currently in widespread commercial use; STEP 2 — CLAIM CHARTS: prepare claim charts showing how the patent claims read on accused products in the market; buyers want to see that the patent claims map to real products; claim charts are often the single most important factor in buyer interest; STEP 3 — LICENSING HISTORY: compile any existing licenses, settlement agreements, and licensing revenue; buyers pay a premium for patents with an established licensing track record; STEP 4 — TITLE CHAIN: ensure clean title — all inventors assigned their rights, all employees signed PIIAs, all prior owners in the chain recorded at the USPTO; title problems kill deals; STEP 5 — ENCUMBRANCES: identify any licenses, covenants not to sue, or FRAND commitments that limit who the buyer can assert the patent against; buyers heavily discount patents with broad license encumbrances; STEP 6 — VALUATION: get an independent valuation or at minimum a comparable transaction analysis; understand the market before engaging a broker to avoid undervaluing.

A typical patent brokerage transaction follows a structured process: PHASE 1 — ENGAGEMENT (weeks 1-4): seller engages broker; broker evaluates portfolio; engagement letter executed (sets commission rate, exclusivity period, often 90-180 days); PHASE 2 — MARKETING MATERIALS (weeks 2-6): broker prepares teaser (blind package — does not identify seller; identifies technology; may include patent numbers); full package (prepared for buyers who sign NDA; includes claim charts, landscape analysis, licensing history, title analysis); PHASE 3 — BUYER OUTREACH (weeks 4-12): broker sends teasers to curated list of potential buyers; receives NDA requests; shares full package with NDAs executed; receives indications of interest (IOIs); PHASE 4 — DUE DILIGENCE (weeks 8-16): interested buyers conduct: (a) claim construction analysis; (b) freedom-to-operate analysis (does the patent cover the buyer's existing products?); (c) validity analysis (prior art search); (d) title chain review; (e) encumbrance review; PHASE 5 — BIDS AND NEGOTIATION (weeks 10-18): broker sets a bid deadline; receives bids; negotiates with top bidders; may conduct a 'best and final offer' round; PHASE 6 — LOI AND EXCLUSIVITY: winning bidder submits a letter of intent (LOI); seller grants exclusivity for final due diligence and documentation; PHASE 7 — CLOSING (weeks 16-24): negotiate and execute patent assignment agreement; buyer pays purchase price; seller executes patent assignments (one per patent family); USPTO assignment recorded within 3 months; closing typically takes 2-4 weeks after LOI; TYPICAL TIMELINE: 4-6 months from engagement to close (larger portfolios can take 9-12 months).

Patent valuation in transactions is part science, part art — and ultimately a negotiation: VALUATION APPROACHES: (a) INCOME APPROACH: the most commonly used; project future licensing income the patent could generate; discount to present value; requires assumptions about royalty rate, royalty base (how many potential infringers?), likelihood of licensing success, and discount rate; (b) MARKET COMPARABLE APPROACH: look at prices paid for similar patents in comparable transactions; difficult because most patent transactions are confidential; data sources include Richardson Oliver Intelligence, Cipher transaction databases, and published court-ordered sale records; (c) COST APPROACH (rarely used): what it would cost to recreate the patent portfolio; least relevant for established portfolios; KEY VALUE DRIVERS: (1) CLAIM BREADTH AND CLARITY: how broad is the independent claim? Does it cover current technology or only legacy approaches?; (2) PRODUCT COVERAGE: do the claims read on commercially significant products currently in use?; (3) REMAINING TERM: 20-year term from filing date; a patent with 15 years remaining is far more valuable than one with 3 years; (4) FORWARD CITATION COUNT: heavily cited patents are often foundational and more valuable; (5) LICENSING HISTORY: established royalty rate evidence; settled cases validate the patent's assertion value; (6) CLAIM MAPPING QUALITY: are there strong claim charts showing infringement of widely deployed products?; (7) ENCUMBRANCES: prior licenses, covenants not to sue, FRAND commitments dramatically reduce value; BUYER TYPE AFFECTS PRICE: operating company defensive buyer — values patent as a deterrent; may pay a defensive premium; PAE buyer — values patent on its assertion potential; typically pays 2-5x annual potential licensing revenue; patent pool / aggregator — values based on pool membership pricing models.

The legal structure of a patent sale is straightforward but requires attention to detail: ASSIGNMENT vs. LICENSE: an assignment transfers ownership (title) in the patent; a license conveys only contractual rights to practice the invention; patent sales involve assignments; WRITTEN REQUIREMENT: § 261: assignments of patents must be in writing; verbal patent assignments are not legally effective; WHAT IS ASSIGNED: the seller assigns: the patent and all continuations, continuations-in-part, divisionals, and foreign counterparts; all past, present, and future rights to sue for infringement; all claims for past damages (unless excluded); all rights under US and foreign patent law; TITLE CHAIN: the assignment must include a complete chain of title back to the inventor; the patent assignment agreement typically includes a representation and warranty of clean title; RECORDING AT USPTO: the assignment must be recorded with the USPTO; 35 U.S.C. § 261: if not recorded within 3 months, a subsequent purchaser without notice takes priority; recording provides constructive notice to subsequent purchasers; WHAT THE AGREEMENT MUST INCLUDE: (a) identification of the patents being assigned (by patent number; for applications, by application number); (b) representations and warranties: seller's ownership; no encumbrances (or disclosure of known encumbrances); inventor assignments obtained; no obligations to standards bodies (or disclosure of FRAND commitments); (c) covenant not to sue: seller may retain a covenant not to sue for its own products even after assignment; (d) purchase price and payment terms; (e) closing conditions; ASSET vs. ENTITY PURCHASE: if patents are in an entity being acquired (merger or stock purchase), assignment may not be needed — the buyer inherits the assets through the entity; but verify: change-of-control clauses in licenses may terminate licenses upon acquisition.